Skip to content

Synopsys

US · SNPS #304 by market cap Listed 1970
396.17 -34.74 -8.06%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Price chart

Pre-market 424.54 -1.48%
After-hours 402.90 +1.70%
Overnight 428.60 -0.54%
534.56367.70396.172026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on SNPS?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is +1.2% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has risen to 3.3% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days D → D

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-21 20:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall C+
ValuationGrowthProfitMomentumHealthAnalyst
Valuation F

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 69.3x Better than 6%
Forward P/E 72.7x Better than 5%
Price / Sales 9.3x Better than 11%
P/E vs own 5-yr range 92nd pctl Better than 12%
Growth B

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 15.2% Better than 76%
Net income CAGR (3Y) 10.6% Better than 60%
Free cash flow CAGR (3Y) -5.5% Better than 32%
Profitability B

How much profit the business keeps from each dollar of sales and capital.

Gross margin 77.0% Better than 88%
Operating margin 13.0% Better than 59%
Net margin 18.9% Better than 78%
Return on equity 7.1% Better than 42%
Return on invested capital 5.7% Better than 48%
Momentum C+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -0.4% Better than 72%
6-month return -24.5% Better than 23%
12-month return (ex latest month) 8.8% Better than 44%
Distance below 52-week high 26.6% Better than 48%
Financial Health C+

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 1.6x Better than 45%
Debt to assets 29.6% Better than 42%
Interest coverage 4.1x Better than 52%
Free cash flow / net income 101.3% Better than 38%
Analyst View A-

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 94.7% Better than 77%
Upside to average target 49.1% Better than 66%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -12.97%
1M -11.49%
3M -0.44%
6M -20.60%
YTD -15.66%
1Y +2.74%
3Y -26.84%
5Y +10.68%

Key statistics

Price & volume

Prev close
430.91
Open
425.00
Day range
394.77 - 432.29
Avg price
405.58
Volume
2.44M
Turnover
989.02M
Amplitude
8.71%
52-week range
362.55 - 539.48

Valuation

P/E
49.27
P/E (TTM)
69.26
P/B
2.44
EPS
8.04
Net profit
1.54B
Net assets
31.15B

Share structure

Market cap
75.92B
Float cap
75.50B
Shares out
191.64M
Float shares
190.56M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 19% of range
362.55 539.48

26.6% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+5.30M net over the window

Short interest

Shares short
6.31M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Synopsys (SNPS)?

Synopsys last traded at 396.17. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Synopsys's market cap?

About 75.92B.

What is the P/E ratio of Synopsys?

The trailing twelve-month P/E is 69.26, above its own 5-year average of 51.80 — toward the top of its historical range (92.19% percentile). See the Valuation tab for the full history.

Does Synopsys pay a dividend?

Synopsys does not currently pay a regular dividend.

Is Synopsys a buy according to analysts?

The consensus of 18 analysts is a Buy rating, with an average 12-month price target of 588.44, which implies 48.5% upside from the current price. This is not investment advice.

What is Synopsys's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Synopsys a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-11-20 20:02:32 · For reference only, not investment advice and not tailored to your situation.

Synopsys discussion 0 comments

Add a comment